Based upon the discrepancy in NASH/NAFLD and HCC incidence between the sexes, the role of the male nuclear sex hormone receptor, the androgen receptor (NR3C4/AR), in HCC progression has been investigated. This evidence concerns the gene AR and hepatocellular carcinoma.